Terumo BCT Inc - Company Profile
Powered by 
All the sales intelligence you need on Terumo BCT Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Terumo BCT Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Terumo BCT Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Terumo BCT Inc (Terumo BCT), a subsidiary of Terumo Corp, provides blood components, therapeutic apheresis, and cellular technologies. The company’s key products include an automated blood collection system, apheresis system, cell processor, cell separation system, information system, data collection system, pathogen reduction technology system, whole blood processing system, cell expansion system, tube sealing device, blood bag system, orbisac system, sterile tubing welder,and ancillary products for blood centers. Its technologies and systems are used in immunotherapy, gene therapy, and cell therapy. Terumo BCT serves blood centers, therapeutic apheresis clinics, researchers, cell collection and processing organizations, hospitals, and private medical practices. The company has manufacturing facilities in India, Japan, Belgium, Northern Ireland, Vietnam, and the US and sells products worldwide through subsidiaries and offices. Terumo BCT is headquartered in Lakewood, Colorado, the US.
Terumo BCT Inc premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| - | - |
| Accel Collection System | Trima Accel |
| Optia Apheresis System | TACSI |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2025 | Contracts/Agreements | In January, the company signed a contract with the Shandong Institute of Medical Devices and Pharmaceutical Packaging Inspection to build a comprehensive platform integrating production, academia, research, and application. |
| 2025 | Contracts/Agreements | In January, the company signed an agreement with FUJIFILM Irvine Scientific to accelerate T-cell expansion using Fujifilm's PRIME-XV T-Cell Expansion Media on Terumo BCT’s Quantum Flex Cell Expansion System. |
| 2024 | Commercial Operation | In November, the company introduced a new global therapy innovations business unit. |
Competitor Comparison
| Key Parameters | Terumo BCT Inc | GE HealthCare Technologies Inc | Sartorius AG | Haemonetics Corp | Sotera Health Co |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | Germany | United States of America | United States of America |
| City | Lakewood | Chicago | Goettingen | Boston | Broadview Heights |
| State/Province | Colorado | Illinois | Niedersachsen | Massachusetts | Ohio |
| No. of Employees | 7,900 | 54,000 | 12,627 | 3,023 | 3,000 |
| Entity Type | Private | Public | Public | Public | Public |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Antoinette Gawin | President; Chief Executive Officer | Senior Management | - | - |
| Rusty Spinney | Executive Vice President; Chief Financial Officer | Senior Management | - | - |
| Cindy Ng | Senior Vice President - Global Commercial | Senior Management | - | - |
| Liza Loidolt | General Manager - Cell and Gene Therapy | Senior Management | 2025 | - |
| Janet Johnson | Vice President - Global Regulatory Affairs and Labeling | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer